Redmile Group’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $22.5M | Buy |
|
|||||
|
2025
Q2 | $19.1M | Sell |
|
|||||
|
2025
Q1 | $15.3M | Sell |
|
|||||
|
2024
Q4 | $30.2M | Buy |
|
|||||
|
2024
Q3 | $40.5M | Sell |
|
|||||
|
2024
Q2 | $36.9M | Buy |
|
|||||
|
2024
Q1 | $47.6M | Sell |
|
|||||
|
2023
Q4 | $18.4M | Buy |
|
|||||
|
2023
Q3 | $2.3M | Hold |
|
|||||
|
2023
Q2 | $2.42M | Buy |
|
|||||
|
2023
Q1 | $1.29M | Sell |
|
|||||
|
2022
Q4 | $942K | Sell |
|
|||||
|
2022
Q3 | $2.2M | Hold |
|
|||||
|
2022
Q2 | $3.54M | Sell |
|
|||||
|
2022
Q1 | $6.51M | Sell |
|
|||||
|
2021
Q4 | $16.8M | Sell |
|
|||||
|
2021
Q3 | $25.4M | Sell |
|
|||||
|
2021
Q2 | $36.2M | Sell |
|
|||||
|
2021
Q1 | $50.7M | Sell |
|
|||||
|
2020
Q4 | $58.3M | Sell |
|
|||||
|
2020
Q3 | $50.1M | Buy |
|
|||||
|
2020
Q2 | $67.1M | Hold |
|
|||||
|
2020
Q1 | $46M | Buy |
|
|||||
|
2019
Q4 | $23.7M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $7.24M | Buy |
|